Meet Ultima Genomics at the ctDNA Symposium 2026
We are enthusiastic to discuss how our whole-genome sequencing method, ppmSeq™ for minimal residual disease (MRD) detection is redefining what’s possible in cancer genomics. From accelerating large‑scale studies to enabling earlier, more precise detection of recurrence, Ultima is delivering the power, speed, and resolution researchers need to unlock the next breakthroughs in cancer science.
Poster presentation
Viewable during coffee breaks throughout the session
Decentralized and cost-effective ultrasensitive MRD testing via ppmSeq TM
Presenter: Elena Helman, PhD
Meet with us at the ctDNA Symposium
Request a meeting